Stockscreener 앱 받기
1.42
7.19%
-0.11
시간 외 거래:
1.41
-0.01
-0.70%
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - TradingView
Weiss Ratings Reiterates Sell (E+) Rating for Pacific Biosciences of California (NASDAQ:PACB) - MarketBeat
Detecting price anomalies in Pacific Biosciences of California Inc. with AIEarnings Risk Report & Daily Growth Stock Tips - newser.com
What analysts say about Pacific Biosciences of California Inc P09 stockHealthcare Stock Analysis & Rapid Profit Growth - earlytimes.in
How HiFi sequencing achieves scalable microbial genomics without compromise - PacBio
Forecasting Pacific Biosciences of California Inc. price range with options dataWeekly Investment Recap & Community Verified Trade Alerts - newser.com
Is Pacific Biosciences of California Inc. (P09) stock resilient in recession scenariosIndex Update & Stock Portfolio Risk Management - newser.com
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell - MSN
Why Is PacBio (PACB) Stock Soaring Today - Yahoo Finance
PacBio (PACB) Technology Chosen for Major Longevity Study - GuruFocus
7,800 Genomes & Epigenomes: PacBio Powers Long Life Family Study with Revio, Q4 2025 Start - Stock Titan
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
PacBio Expands Partnership with seqWell to Distribute LongPlex™ Multiplexing Kit for Enhanced Genomic Sequencing Solutions - Quiver Quantitative
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs - Yahoo Finance
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today - sharewise.com
Is Pacific Biosciences of California Inc. (P09) stock a buy before new product rollout2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Will Pacific Biosciences of California Inc. stock outperform Nasdaq indexJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Why Pacific Biosciences of California Inc. stock is rated strong buy2025 Year in Review & Long-Term Capital Growth Ideas - newser.com
Is this a good reentry point in Pacific Biosciences of California Inc.July 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Will Pacific Biosciences of California Inc. rebound enough to break evenJuly 2025 Earnings & Verified Momentum Watchlists - newser.com
Is Pacific Biosciences of California Inc. a candidate for recovery playJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Applied Materials, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Heatmap analysis for Pacific Biosciences of California Inc. and competitorsWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Barclays Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $1.5 - 富途牛牛
Can volume confirm reversal in Pacific Biosciences of California Inc.Portfolio Growth Summary & Weekly Breakout Watchlists - newser.com
Can swing trading help recover from Pacific Biosciences of California Inc. losses2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
Powered by PacBio: Selected publications from September 2025 - PacBio
Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional owners may be pleased with recent gains after 16% loss over the past year - simplywall.st
PacBio Enters Carrier Screening Market With PureTarget Expansion - sharewise.com
What drives Pacific Biosciences of California Inc P09 stock priceGlobal Market Influence & Outstanding Investment Returns - earlytimes.in
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Best data tools to analyze Pacific Biosciences of California Inc. stockJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Pacbio’s Puretarget simplifies carrier screening - BioWorld MedTech
1.83%
자본화:
|
볼륨(24시간):